Clinical Trials Browser

Phase 3 × INDUSTRY × Blood Specimen Collection × Clear all

NCT03355820 2020-11-19

A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study

Phase 3 Completed

228 enrolled 11 charts

Uterine Cervical Dysplasia

NCT00947115 2020-10-30

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

Phase 3 Completed

525 enrolled 24 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT02100618 2015-07-20

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Phase 3 Withdrawn

Papillomavirus Infections

NCT01209013 2012-05-08

Oedisse

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus